HIGHLIGHTS
- who: Anne Gomez-Brouchet and collaborators from the Department of Pathology, CHU, IUCT-Oncopole, University of Toulouse, Eq ONCOSARC CRCT, , CNRS, Toulouse, France have published the research work: Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?, in the Journal: Cancers 2021, 423 of 15/01/2021
- what: The authors demonstrate that ZA not only acts on harmful osteoclasts but also on protective macrophages and hypothesize that the bipotent CD68+/CD163+ macrophages might present novel therapeutic targets. The study showed that ZA did not improve the outcome . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.